Delivery Order SPE2DB24D2106-SPE2DB25FAVPP

Award Date 6/17/25
Potential Completion Date 7/10/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,997.21, is for the delivery of PROMACTA 25 MG TABLET UU 30S, with a completion date of May 16, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,418.06 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET UU 30S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
This federal contract award, valued at $4,418.06, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order for the pharmaceutical product "PROMACTA 25 MG TABLET UU 30S" and has a firm fixed-price pricing type with a completion date of May 6, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,418.06 firm fixed-price delivery order is for the supply of 4,568,160,321 units of the prescription drug Promacta 25 mg tablets. The contract has an ultimate completion date of May 28, 2025 and was awarded on May 6, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,997.21 firm fixed-price contract is for the provision of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product. The contract has no set-aside designation and is a delivery order placed under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999. This IDC, under...
This is a delivery order award under contract SPE2DB24D2106 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $21,727.74 firm fixed-price contract is with the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including PROMACTA 50 mg tablets. This award is not associated with any set-aside program. DMS Pharmaceutical Group holds an indefinite delivery contract, SPE2DB24FATWX, with DLA valued up to $4,999,999 through 2025...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $41,870.16 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the provision of 4566788112 - ICLUSIG 15 MG TABLET 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of January 10, 2025 and was awarded on December 18, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $35,995.42, has a completion date of July 2, 2024 and is not set aside. DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical...
This firm-fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,632.54 contract has an ultimate completion date of May 21, 2025 and covers the delivery of various pharmaceutical products, including prescription medications, over-the-counter drugs, biologics, and medical consumables. DMS Pharmaceutical Group...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $18,488.12 firm fixed-price contract has a completion date of June 18, 2025 and covers the provision of pharmaceutical products and medical supplies to federal healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAVPP
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $4,418.06 and has an ultimate completion date of July 10, 2025. It covers the delivery of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product, to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. This positioning establishes DMS Pharmaceutical Group Inc. as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 9/16/25, 10:01 AM